AEON Biopharma, Inc. (AEON)

AEON Biopharma Statistics

Total Valuation

AEON Biopharma has a market cap or net worth of $9.20 million. The enterprise value is $16.79 million.

Market Cap	9.20M
Enterprise Value	16.79M

Important Dates

The next estimated earnings date is Wednesday, November 12, 2025, after market close.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

AEON Biopharma has 11.64 million shares outstanding. The number of shares has decreased by -94.62% in one year.

Current Share Class	11.64M
Shares Outstanding	11.64M
Shares Change (YoY)	-94.62%
Shares Change (QoQ)	+177.80%
Owned by Insiders (%)	29.18%
Owned by Institutions (%)	16.72%
Float	8.20M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.12

Current Ratio	1.12
Quick Ratio	0.92
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-129.01%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-708.80%
Revenue Per Employee	n/a
Profits Per Employee	-$327,200
Employee Count	5
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -98.53% in the last 52 weeks. The beta is 0.71, so AEON Biopharma's price volatility has been lower than the market average.

Beta (5Y)	0.71
52-Week Price Change	-98.53%
50-Day Moving Average	0.76
200-Day Moving Average	8.13
Relative Strength Index (RSI)	54.96
Average Volume (20 Days)	78,126

Short Selling Information

The latest short interest is 155,882, so 1.34% of the outstanding shares have been sold short.

Short Interest	155,882
Short Previous Month	328,300
Short % of Shares Out	1.34%
Short % of Float	1.90%
Short Ratio (days to cover)	1.74

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-17.95M
Pretax Income	n/a
Net Income	-1.64M
EBITDA	-17.87M
EBIT	-17.95M
Earnings Per Share (EPS)	-$0.40

Balance Sheet

The company has $8.44 million in cash and $16.44 million in debt, giving a net cash position of -$8.00 million or -$0.69 per share.

Cash & Cash Equivalents	8.44M
Total Debt	16.44M
Net Cash	-8.00M
Net Cash Per Share	-$0.69
Equity (Book Value)	-15.85M
Book Value Per Share	-1.37
Working Capital	1.13M

Cash Flow

In the last 12 months, operating cash flow was -$13.58 million and capital expenditures -$4,000, giving a free cash flow of -$13.58 million.

Operating Cash Flow	-13.58M
Capital Expenditures	-4,000
Free Cash Flow	-13.58M
FCF Per Share	-$1.17

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AEON Biopharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	94.62%
Shareholder Yield	94.62%
Earnings Yield	-18.61%
FCF Yield	-154.48%

Analyst Forecast

The average price target for AEON Biopharma is $360.00, which is 45,446.56% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$360.00
Price Target Difference	45,446.56%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on February 26, 2025. It was a reverse split with a ratio of 1:72.

Last Split Date	Feb 26, 2025
Split Type	Reverse
Split Ratio	1:72

Scores

Altman Z-Score	n/a
Piotroski F-Score	1